Clinical trial Recruiting at 1 site Interventional Ages 11 to 14

Understanding how puberty and testosterone affect adolescent mood

Official title: Probing the Neurophysiological Mechanisms Underlying Sex-specific Testosterone-mood Relationships During Puberty: A Randomized Controlled Trial Using a Smartphone-based Training Program

Run by University of North Carolina, Chapel Hill · NCT06072677 · Data updated 2026-11-12

This study is trying to see how puberty and testosterone affect the moods of boys and girls aged 11 to 14 who have had stress or mild depression.

Quick facts

Study typeInterventional
Ages11 Years to 14 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of North Carolina, Chapel Hill
Academic / other
Locations1 site (Chapel Hill, North Carolina)
StatusRecruiting
StartedAugust 24, 2023
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedJanuary 14, 2026
Trial IDNCT06072677 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 11 to 14 who have experienced a stressful life event or show signs of moderate depression.

Probably not a fit

Patients with a history of manic episodes, psychotic symptoms, or those currently taking medications that affect neurological function may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research investigates the differences in mood disorders between male and female adolescents during puberty, focusing on how sex hormones may influence these conditions. It aims to identify sex-specific neural and endocrine features that contribute to the increased risk of depression in females and externalizing disorders in males. Participants aged 11 to 14 who have experienced stress or moderate depression will engage with the Healthy Minds Program, utilizing mobile apps to track their mood and responses to hormonal changes.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and treatment strategies for adolescent mood disorders.

How similar studies have gone: While there is ongoing research into adolescent mood disorders, this specific focus on sex-specific pathways during puberty is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Between the ages of 11 and 14
* Have their own personal mobile device and capability to download the MyCap and Healthy Minds apps
* Experienced a stressful life event within the last year, or endorse moderate depression (defined by a CES-DC score 16 or higher)

Exclusion Criteria:

* Previous experience with the Healthy Minds Program
* Regular meditation practice
* Current or history of manic episodes, psychotic symptoms, or current suicidal intent
* Taking any form of exogenous hormones or intrauterine device (IUD) within one month of participation in the study
* Taking medications that directly alter cardiovascular or neurological function

Where it's running

  • Carolina Crossing B, Suite 1
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Elizabeth Andersen, PhD — University of North Carolina, Chapel Hill
  • Study coordinator: Kayla Jensen, BS
  • Email: nerdlab@unc.edu
  • Phone: 919-445-6815

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Light color therapy to help chronic pain

    This small crossover study tests whether colored light (S-cone chromatic light) can reduce pain in adults with fibromyalgia or chronic widespread pain compared with white light over two 7-day periods.

    Recruiting University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT07825792

  • Personalized PandA-tACS for Antenatal Depression

    This study tests whether a single personalized brain stimulation session can help pregnant people with depression more than a standard or sham stimulation.

    Recruiting University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT07799480

  • Melanin-Adjusted Blood Oxygen Sensor in ICU Patients

    This study tests a new pulse oximeter that adjusts for skin pigment to see if it gives accurate oxygen readings in ICU patients.

    Recruiting University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT07799454

  • Daily Upgrade: Can an essential amino acid supplement help active women improve body composition and metabolism?

    This study tests whether Daily Upgrade EAA+ helps healthy, active women by comparing it with whey protein and placebo before HIIT, and by using it daily for three weeks with twice-weekly HIIT workouts.

    Recruiting University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT07792603

  • Potassium-Competitive Acid Blockers in Barrett’s Esophagus on PPI Therapy

    This study tests whether vonoprazan, a potassium-competitive acid blocker, can better reduce acid reflux in adults with nondysplastic Barrett’s esophagus who are already taking a daily PPI.

    Recruiting Phase 4 University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT07788742

  • Long-Term Look at Long COVID after COVID-19

    Researchers will see how common Long COVID is and how symptoms stick around over time in adults who had COVID-19, using questionnaires and saliva samples to look for biological clues.

    Recruiting University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT07781501

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.